PEKIN, Ill., Sept. 14, 2026 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel, essential ingredients and specialty alcohols, today announced that management will take part in the H.C. Wainwright 28th Annual Global Investment Conference, conducting one-on-one meetings throughout the day on Tuesday, September 15, 2026.

About Alto Ingredients, Inc.
Alto Ingredients, Inc. (NASDAQ: ALTO) is a leading producer and distributor of renewable fuels, essential ingredients and specialty alcohols. Leveraging the unique qualities of its facilities, the company serves customers in a wide range of consumer and commercial products in the Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. For more information, please visit www.altoingredients.com.

Media and Company IR Contact:
Michael Kramer, Alto Ingredients, Inc., 916-403-2755
Investorrelations@altoingredients.com 

IR Agency Contact:
Jody Burfening, Alliance Advisors Investor Relations, 212-838-3777
Investorrelations@altoingredients.com

First advance under second tranche brings total drawn under the DOE facility to $178 million and supports 4 GWh of annual battery manufacturing capacity in Western Pennsylvania

PITTSBURGH, Sept. 14, 2026 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), America’s leading innovator in designing, manufacturing, and providing zinc-based long-duration energy storage (LDES) systems sourced and manufactured in the United States, today announced it has received an $87 million first advance under the second tranche of its loan agreement with the U.S. Department of Energy’s (DOE) Office of Energy Dominance Financing (EDF).

The advance reimburses 80% of eligible costs associated with the Company’s Thorn Hill manufacturing facility in Warrendale, Pennsylvania. Eos has now drawn a total of approximately $178 million of its DOE facility since 2024.

Line 2 entered commercial production in June 2026 and is being ramped toward its designed annual manufacturing capacity of approximately 2 GWh. Upon completion of the planned relocation of line 1 to Thorn Hill, subject to lender approvals, Eos expects Thorn Hill to support approximately 4 GWh of annual manufacturing capacity across two lines.

“Loan funding from the Office of Energy Dominance Financing has been critical in scaling Eos,” said Alessandro Lagi, Chief Financial Officer of Eos. “This advance reimburses a significant portion of the investment we have already made in Line 2 and returns that capital to the balance sheet, giving us more room to invest in the business while maintaining a disciplined approach to growth.”

“Running two lines under one roof drives more efficient use of our engineering, support resources, and labor,” said John Mahaz, Chief Operating Officer of Eos. “This enables the operation to increase productivity and optimize manufacturing cost.”

Eos expects to create jobs across 4 shifts to staff Line 2 in the Western Pennsylvania facility. The line continues to ramp toward full production as additional shifts come online, consistent with the Company’s phased manufacturing scale-up strategy.

About Eos Energy Enterprises

Eos is accelerating the shift to American energy independence with positively ingenious solutions that transform how the world stores power. The Company’s BESS features the innovative Znyth™ technology, a proven chemistry with readily available non-precious earth components, that is the pre-eminent safe, non-flammable, secure, stable, and scalable alternative to conventional technology. The Company’s BESS is ideal for utility-scale, microgrid, commercial, and industrial long-duration energy storage applications (i.e., 4 to 16+ hours), and provides customers with significant operational flexibility to effectively address current and future increased grid demand and complexity. For more information about Eos (NASDAQ: EOSE), visit eose.com.

Contacts

Investors: ir@eose.com
Media: media@eose.com

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the expected use and benefits of the loan proceeds; the continued development, installation, startup, operation, and ramp-up of Line 2; the expansion and scaling of Eos’ manufacturing operations and domestic manufacturing capacity; the timing and achievement of targeted production levels and annual manufacturing capacity; the anticipated staffing, hiring, and job creation associated with Line 2; the availability of future advances under the DOE-guaranteed loan facility; the receipt of any required lender or governmental approvals; and Eos’ ability to execute its growth strategy, and other statements that are not historical facts. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on our management’s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

Important factors that could cause actual results to differ materially include, among others, risks relating to Eos’ ability to satisfy the conditions applicable to future advances under the DOE-guaranteed loan facility; complete, commission, operate, and ramp Line 2 on the anticipated schedule and within the applicable budget; achieve targeted production rates, staffing levels, hiring objectives, and manufacturing capacity; manage construction, equipment, supply-chain, labor, startup, and operational risks; obtain and maintain required governmental and third-party approvals; comply with the DOE loan documents and other financing arrangements; maintain adequate liquidity and secure additional financing when needed; realize anticipated manufacturing efficiencies, productivity improvements, cost benefits, and operational synergies associated with consolidating manufacturing activities; and scale manufacturing operations, and other risks described in Eos’ filings with the Securities and Exchange Commission (“SEC”).

Additional information concerning these and other risk factors is contained in the Company’s filings with the SEC, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

Forward-looking statements speak only as of the date they are made. Should one or more of these risks or uncertainties materialize or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Initial members bring global rare earths leadership, direct Skaergaard technical knowledge, and proven mine-development and operating experience in Greenland

Advisory Board to support project strategy, studies, permitting, partnerships and the Company’s North Atlantic Critical Metals Corridor

CHARLOTTE, N.C., Sept. 14, 2026 (GLOBE NEWSWIRE) — via IBN – Greenland Mines Ltd. (Nasdaq: GRML) (“Greenland Mines” or the “Company”) today announced the formation of a Strategic Advisory Board and the appointment of its three initial members: Constantine E. Karayannopoulos, Thomas Abraham-James, and Bent Olsvig Jensen.

The Strategic Advisory Board brings together complementary capabilities across the full development pathway for Greenland Mines’ two flagship assets: global rare earth markets, processing and downstream supply chains; direct technical and operating history at the Skaergaard Palladium-Platinum-Gold project; and practical mine development, operations, logistics and stakeholder engagement in Greenland including managing and operation experience from the nearby anorthosite mine only 40 km away from Greenland Mines’ Sarfartoq Neodymium-Praseodymium Rare Earth Project.

Greenland Mines intends to appoint two to three additional members as it continues to broaden the expertise and relationships available to management and the Company’s Board of Directors.

“The creation of our Strategic Advisory Board reflects where Greenland Mines is today and where we intend to go next,” said Dr. Bo Møller Stensgaard, President of Greenland Mines.

“Over the past several months, we have completed the acquisition of Sarfartoq, delivered new S-K 1300 Mineral Resource Estimates for both projects and executed the most extensive multidisciplinary field program undertaken at Skaergaard to date.

“We are now advancing from resource definition and data collection into the next stage of technical studies, permitting, commercial engagement and integrated development planning.

“Constantine, Tom and Bent bring an exceptional combination of capabilities for this next phase for the Company and its Sarfartoq Rare Earth Project and Skaergaard Precious and Critical Metals Project.

“Constantine is a transformational addition to Greenland Mines. Over more than three decades, he has built, led and completed major transactions across the international rare earth and critical-materials industries, with experience spanning mineral resources, separation, advanced materials and permanent-magnet supply chains. He combines deep technical and commercial expertise with an exceptional international network across industry, capital markets and governments in North America, Europe and Asia.

“Constantine also brings a direct and highly relevant connection to Sarfartoq. As President and Chief Executive Officer of Neo Performance Materials, he was instrumental in Neo’s decision to acquire and advance Sarfartoq as a potential source of NdPr-rich feedstock for a more diversified Western rare earth supply chain. His ability to connect high-quality mineral resources with processing capacity, strategic partners, government priorities and end markets will be invaluable as we advance Sarfartoq and develop our broader North Atlantic Critical Metals Corridor. He will be an important strategic sounding board for our leadership and a powerful facilitator of the relationships required to move our vision forward.

“Tom brings first-hand knowledge of Skaergaard and a strong record spanning exploration, public markets and company building. Through his leadership of Pulsar Helium, he has also demonstrated an ability to position critical-resource projects within broader strategic supply-chain priorities — combining upstream resource development with processing infrastructure, financing, constructive government engagement and local stakeholder support.

“Bent brings proven Greenland mine-operating experience from the nearby producing Greenlandic anorthosite in West Greenland — only 40 km west of Sarfartoq — and an important understanding of how projects must be planned and executed in close cooperation with Greenlandic authorities, communities, businesses and the local workforce.

“The Advisory Board will be a practical sounding board for strategy, development sequencing and execution. It will also support our work to connect Greenlandic mineral resources with allied processing capabilities, capital, government initiatives and end markets. That is central to our North Atlantic Critical Metals Corridor: not simply moving material from one location to another, but building resilient, responsible and commercially viable links across the upstream, midstream and downstream value chain.”

Initial Advisory Board Members

Constantine E. Karayannopoulos

Mr. Karayannopoulos, BASc, MASc, P.Eng., is an experienced executive and professional engineer with more than 30 years of senior leadership roles in the rare earth elements, critical minerals, and advanced materials sectors. He has held senior executive and board roles across mining, processing and downstream materials businesses globally.

He most recently served as President and Chief Executive Officer of Neo Performance Materials Inc. (NEO) until his retirement in July 2023. During his tenure with NEO and its predecessors from 2000, he held several senior leadership roles including COO, CEO, Chairman, and again CEO from 2020 to 2023.

As CEO of Neo, he oversaw the company’s global expansion and ultimately led the company through its US$1.3 billion acquisition by Molycorp Inc. in 2012. Following the transaction, he served as Vice-Chairman, later becoming interim Chief Executive Officer and Chairman of Molycorp.

Mr. Karayannopoulos is also the co-founder and former non-executive Chairman of Neo Lithium Corp., which developed a major lithium brine project in Argentina before being acquired in 2022 for approximately US$960 million. In addition to his corporate roles, Mr. Karayannopoulos serves as a strategic advisor and board member to several companies in the critical minerals and battery materials sectors.

He has previously served as a director of the Canada China Business Council and sits on the advisory board of the University of Toronto Department of Chemical Engineering and Applied Chemistry. He holds Bachelor and Master of Applied Science degrees in Chemical Engineering from the University of Toronto and is a registered Professional Engineer.

Mr. Karayannopoulos also has direct historical involvement with Sarfartoq. While he was President and Chief Executive Officer of Neo, Neo and Hudson Resources entered into the August 2022 agreement through which Neo pursued Sarfartoq as a potential source of NdPr-rich feedstock for diversified rare earth supply chains. He will advise Greenland Mines on rare earth strategy, processing and product development, market positioning, potential offtake and strategic partnerships, government engagement and relationships across North American and European critical-minerals supply chains.

Thomas Abraham-James

Mr. Abraham-James, BSc (Hons), FAusIMM (CP Geo), FSEG and FGSL, is a geologist, entrepreneur and public-company executive with approximately 20 years of international mineral exploration, project-development and corporate experience. He holds a Bachelor of Science degree with First-Class Honours in Geology from the Australian National University. His honours research examined the evolution and mineralization of South Africa’s Bushveld Complex, one of the world’s most significant platinum-group-metal systems. He began his professional career as a mine geologist with Rio Tinto at the Argyle Diamond Mine before moving into international mineral exploration.

From 2008 to 2012, Mr. Abraham-James served as Exploration Manager of Platina Resources Limited, where he managed the company’s 2008, 2009 and 2010 Greenland field seasons and worked directly on Skaergaard. His first-hand knowledge of the Project’s geology, mineralized horizons, historical technical programs and Arctic field operations provides Greenland Mines with valuable continuity as the Company integrates legacy knowledge with its current S-K 1300 work, metallurgical testing and engineering studies.

Mr. Abraham-James subsequently co-founded Helium One Global Ltd, the first publicly listed company focused specifically on primary helium exploration; founded Greenland-focused Longland Resources Ltd, which was later acquired by Conico Ltd; and co-founded Pulsar Helium Inc., where he currently serves as Chief Executive Officer and a director. He has also contributed to the development of modern primary-helium exploration methodologies and co-authored technical publications, including The Principles of Helium Exploration.

Through these roles, Mr. Abraham-James has built experience across project generation, technical-program design, financing, public markets, processing and commercialization strategy, government engagement and the positioning of critical-resource projects within resilient Western supply chains. He will advise Greenland Mines on Skaergaard’s technical and development strategy, exploration and study design, Greenland field execution, corporate development, strategic partnerships and capital-markets positioning.

Bent Olsvig Jensen

Mr. Olsvig Jensen is a Greenland-based mining executive with approximately 30 years of leadership and operating experience in Greenland across education, the fishing industry, logistics, project management, mineral exploration and mine development. He holds a Bachelor of Education from Aalborg Seminarium and has completed postgraduate studies in educational administration, institutional development, information technology and economics, together with Danish military leadership training.

Mr. Olsvig Jensen has held senior executive roles associated with two of the relatively few Greenland mining projects to have progressed into operation since Greenland assumed responsibility for its mineral resources in 2010. From 2011 to 2016, he served as Chief Executive Officer of True North Gems Greenland during the development, permitting and construction phases of the Aappaluttoq ruby project. He subsequently served as Chief Executive Officer of Xploration Services Greenland, leading a Greenlandic service company that provided operational and turnkey support to mineral-exploration and development projects across the country.

From 2020 through August 2026, Mr. Olsvig Jensen served as Managing Director in Greenland for Lumina Sustainable Materials, leading the development and operation of the White Mountain, or Qaqortorsuaq, anorthosite mine in the Kangerlussuaq fjord region near Sarfartoq. His experience encompasses project financing, operational planning, Arctic logistics and infrastructure, regulatory compliance, workforce and contractor management, government relations, community engagement and the export of Greenlandic mineral products to international markets.

Mr. Olsvig Jensen has chaired the Mineral Resources Industry Committee of the Greenland Business Association since 2020 and, through that position, serves on the association’s board, representing the interests of Greenland’s exploration and mining sector. He also chairs Iserit A/S, the Nuuk municipality-owned property-management company. He founded NEMCo – Nuna Exploration & Mining Consultancy and, following his departure from Lumina, is focusing the consultancy on responsible mineral development and engagement among companies, investors, authorities, communities and other Greenlandic stakeholders.

Mr. Olsvig Jensen’s combination of mine-operating experience, corporate leadership and deep knowledge of Greenlandic society and Arctic operating conditions will be particularly valuable as Greenland Mines advances Sarfartoq into engineering, infrastructure, environmental and social assessment, permitting and feasibility-stage work. He will advise the Company on practical mine development and operations, logistics and infrastructure, permitting strategy, local participation and workforce development, and engagement with Greenlandic authorities, communities and businesses.

Advisory Capability for the Next Phase

The appointments follow a period of rapid project and corporate advancement. Greenland Mines completed the acquisition of Sarfartoq on September 1, 2026, after receiving approval from Naalakkersuisut, the Government of Greenland.

The Sarfartoq Project’s recently published Initial Assessment reported a high-case pre-tax NPV at an 8% real discount rate of approximately US$2.05 billion and a pre-tax IRR of 118.6%, including Indicated and Inferred Mineral Resources. At 2025 consumption levels, planned annual NdPr oxide production attributable to ST1 alone would represent approximately 34% of NdPr oxide refined outside China during each of the Project’s nine scheduled operating years.

Sarfartoq’s maiden 2026 S-K 1300 Mineral Resource Estimate, effective July 31, 2026, established the Project’s first Indicated Mineral Resource under an SEC-recognized standard. The preferred hybrid open-pit and underground configuration comprises 12.2 million tons in total, including 6.90 million tons Indicated at 1.60% total rare earth oxides (“TREO”) and 5.34 million tons Inferred at 0.96% TREO. Its strategic strength lies not only in grade but in the value composition of the basket: neodymium and praseodymium represent 83.9% of modeled in-concentrate basket value, with terbium and dysprosium contributing a further 8.5%. Neo Performance Materials retains previously announced offtake rights for up to 60% of future Sarfartoq ore or mineral concentrate production, providing a potential connection to Western-allied rare earth separation and magnet capacity.

Greenland Mines’ next phase at Sarfartoq is directed toward an application to Naalakkersuisut for an exploitation license. In parallel, the Company is planning a technical program for Sarfartoq covering resource upgrading, engineering, infrastructure assessment and scaled metallurgical and processing-flowsheet test work, with the objective of advancing to a Pre-Feasibility Study while continuing discussions regarding additional offtake and strategic partnerships. Two years of environmental baseline field studies have now been completed, providing a foundation for planned environmental and social impact assessment studies.

At Skaergaard, the Company’s 2026 S-K 1300 Mineral Resource Estimate, effective July 3, 2026, reported 153.6 million tons of Indicated Mineral Resources containing 7.57 million ounces of palladium, 3.19 million ounces of gold and 0.60 million ounces of platinum, equivalent to 15.00 million ounces on a palladium-equivalent basis. A further 177.5 million tons of Inferred Mineral Resources contain 7.75 million ounces of palladium, 4.28 million ounces of gold and 0.60 million ounces of platinum, equivalent to 17.49 million palladium-equivalent ounces. The estimate uses a net smelter return cut-off of US$84 per ton based on an underground mining scenario and covers only approximately one-quarter to one-third of the intrusion hosting the defined precious-metal horizons.

The extensive 2026 Skaergaard field campaign is now being concluded after generating the data and material required for the next stage of project evaluation. Operating from the ice-class M/V Argus as an offshore logistics platform, the multidisciplinary program included drilling and geotechnical work relevant to potential open-pit and underground scenarios; a seven-site bulk-sampling program that collected approximately 104.8 tons of mineralized and host material for large-scale and pilot-scale metallurgical test work; bathymetric, photogrammetric and ground-penetrating radar surveys; environmental baseline work; and on-site studies covering mine engineering, infrastructure, processing, tailings and waste-rock management.

The results of this program are intended to feed directly into resource evaluation, pilot-plant processing work, a maiden Initial Assessment, planned Pre-Feasibility Study work and the technical and environmental workstreams required to support a future exploitation-license application. No Initial Assessment or Pre-Feasibility Study has yet been completed for Skaergaard, no Mineral Reserve has been declared, and no production decision has been made.

Building the North Atlantic Corridor

The Strategic Advisory Board will also support Greenland Mines’ broader North Atlantic Critical Metals Corridor strategy, which is designed to connect responsibly developed Greenlandic resources with processing, infrastructure, industrial partners and end markets in allied jurisdictions.

For Sarfartoq, the previously announced relationship with Neo Performance Materials provides a potential route from an NdPr-rich Greenlandic resource to established European separation and magnet capacity. For Skaergaard, high-value, low-volume precious-metal products may offer comparatively flexible export options, while potential VTM-derived products would require a more energy- and infrastructure-intensive solution. Greenland Mines therefore holds a First Right of Refusal over the Helguvík industrial site in Iceland, a brownfield former silicon-metal facility approximately 400 kilometers by sea from Skaergaard, with deep-water port access, existing industrial infrastructure and access to Iceland’s renewable-power system.

Together, these potential routes form a strategic Greenland-to-allied-processing concept spanning rare earth magnet materials, precious metals and critical-mineral by-products.

The Corridor remains a development strategy: its processing configurations, logistics, power requirements, economics, partnerships and permitting remain subject to future technical, commercial, environmental and economic studies.

The Advisory Board is intended to help the Company test those assumptions, identify the right counterparties and sequence the work required to translate that strategy into executable project pathways.

About Greenland Mines Ltd

Greenland Mines Ltd is a Nasdaq-listed resource development and mining company focused on the development of the Skaergaard Project in southeast Greenland and the Sarfartoq neodymium-praseodymium rare earths project in southwest Greenland. The Company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and select midstream processing opportunities, while advancing its assets and broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure.

Technical Information

The scientific and technical information in this news release relating to Skaergaard is derived from the Company’s July 15 and September 11, 2026 news releases and the S-K 1300 Technical Report Summary referenced therein. The scientific and technical information relating to Sarfartoq is derived from the Company’s August 24, August 25 and September 2, 2026 news releases and the S-K 1300 Technical Report Summaries referenced therein. Readers should review those disclosures and the full Technical Report Summaries for the assumptions, qualifications and cautionary statements applicable to the Mineral Resource Estimates and Initial Assessment.

The Sarfartoq Initial Assessment is preliminary in nature and includes Inferred Mineral Resources that are considered too speculative geologically to have modifying factors applied to them that would enable them to be categorized as Mineral Reserves. There is no certainty that the results of the Initial Assessment will be realized, and no Mineral Reserves have been estimated for Sarfartoq. Mineral Resources are not Mineral Reserves and do not have demonstrated economic viability. Field-measured tonnage from the Skaergaard bulk-sampling program is preliminary and subject to confirmation during the next phase of test work. Potential Skaergaard by-products, processing routes and development configurations remain conceptual and are not supported by an economic study.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “potential,” “could,” “may,” “will,” “should,” “estimate,” “objective” and similar expressions. These forward-looking statements include, but are not limited to, statements regarding: the intended role, activities and expected contributions of the Strategic Advisory Board and its members; the expected appointment of additional members; plans and timing for resource upgrading, metallurgical testing, engineering, environmental and social studies, Initial Assessments, Pre-Feasibility Studies and exploitation-license applications; potential production, processing, infrastructure, logistics, offtake and strategic partnerships; planned 2027 and 2028 work; the results and assumptions of the Sarfartoq Initial Assessment; potential future production and supply-chain significance; potential Skaergaard mining, processing and product configurations; the Helguvík industrial site and the North Atlantic Critical Metals Corridor; and the advancement and potential development of Skaergaard and Sarfartoq.

Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties. Many factors could cause actual results to differ materially, including exploration, resource-estimation, metallurgical, engineering, environmental, social, permitting, logistical, infrastructure, financing, commodity-price, market, counterparty and execution risks; the availability and level of participation of advisory board members; changes to planned programs and timelines; the Company’s ability to obtain required approvals and financing; and risks described in documents filed or to be filed with the U.S. Securities and Exchange Commission. No assurance can be given that studies, applications, partnerships, transactions, development decisions or production will occur on the timing contemplated or at all.

Readers should carefully consider these factors and the other risks and uncertainties described in the Company’s SEC filings. All information in this press release is provided as of its date, and the Company undertakes no obligation to update any forward-looking statement except as required by applicable law.

Investor Contact and Corporate Communications:

ir@greenlandmines.com
Website: www.greenlandmines.com

Corporate Communications:

IBN
Austin, Texas
IBN.Ai
512.354.7000 Office

Editor@IBN.Ai

LOUISVILLE, Ky., Sept. 14, 2026 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (Nasdaq: CHDN, “CDI,” “the Company”) announced today that it is launching a proposed $500 million in aggregate principal amount of senior secured Term Loan B due 2033 (“2033 TLB”). 

CDI intends to use the net proceeds from the 2033 TLB (i) to repay outstanding Term Loan B loans, (ii) to partially redeem 5.50% Senior Notes due 2027 (the “2027 Notes”), (iii) to fund related transaction fees and expenses, and (iv) for working capital and other general corporate purposes.

There can be no assurances that the Company will be successful in its marketing efforts or that it will be able to obtain the 2033 TLB. The consummation of the 2033 TLB is subject to market and customary conditions. The 2033 TLB is subject to customary gaming regulatory conditions. This press release is not a notice of redemption for the 2027 Notes.

About Churchill Downs Incorporated

Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) has created extraordinary entertainment experiences for over 150 years, beginning with the Company’s most iconic and enduring asset, Churchill Downs Racetrack, the home of the Kentucky Derby and premier races of the Thoroughbred Championship Series. Headquartered in Louisville, Kentucky, CDI has expanded through the acquisition, development, and operation of live and historical racing entertainment venues, the growth of the online wagering businesses, and the acquisition, development, and operation of regional casino gaming properties. https://www.churchilldownsincorporated.com/

This news release contains various “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are typically identified by the use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “predict,” “project,” “seek,” “should,” “will,” “scheduled,” and similar words or similar expressions (or negative versions of such words or expressions), although some forward-looking statements are expressed differently.

Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from expectations include the following: the occurrence of extraordinary events, such as terrorist attacks, public health threats, civil unrest, and inclement weather, including as a result of climate change; the effect of economic conditions on our consumers’ confidence and discretionary spending or our access to credit, including the impact of inflation; changes in, or new interpretations of, applicable tax laws or rulings that could result in additional tax liabilities; the impact of any pandemics, epidemics, or outbreaks of infectious diseases, and related economic matters on our results of operations, financial conditions, and prospects; lack of confidence in the integrity of our core businesses or any deterioration in our reputation; negative shifts in public opinion regarding gambling that could result in increased regulation of, or new restrictions on, the gaming industry; loss of key or highly skilled personnel, as well as general disruptions in the general labor market; the impact of significant competition, and the expectation that competition levels will increase; changes in consumer preferences, attendance, wagering, and sponsorships; risks associated with equity investments, strategic alliances and other third-party agreements; inability to respond to rapid technological changes in a timely manner; concentration and evolution of slot machine and historical racing machine manufacturing and other technology conditions that could impose additional costs; failure to enter into or maintain agreements with industry constituents, including horsemen and other racetracks; cybersecurity risk, including cybersecurity breaches, loss or misuse of our confidential information as a result of a breach including customers’ personal information, or IT system operational disruptions, could lead to government enforcement actions or other litigation; costs of compliance with increasingly complex laws and regulations regarding data privacy and protection of personal information; reliance on our technology services and catastrophic events, system failures, errors or defects disrupting our operations; inability to identify, complete, or fully realize the benefits of our proposed acquisitions, divestitures, development of new venues or the expansion of existing facilities on time, on budget, or as planned; difficulty in integrating recent or future acquisitions into our operations; cost overruns and other uncertainties associated with the development of new venues and the expansion of existing facilities; general risks related to real estate ownership and significant expenditures, including risks related to environmental liabilities; personal injury litigation related to injuries occurring at our racetracks; compliance with the Foreign Corrupt Practices Act or other similar laws and regulations, or applicable anti-money laundering regulations; payment-related risks, such as risk associated with fraudulent credit card or debit card use; work stoppages and labor problems; risks related to pending or future legal proceedings and other actions; highly regulated operations and changes in the regulatory environment could adversely affect our business; restrictions in our debt facilities limiting our flexibility to operate our business; failure to comply with the financial ratios and other covenants in our debt facilities and other indebtedness; increases to interest rates, disruption in the credit markets or changes to our credit ratings may adversely affect our business; increase in our insurance costs, or inability to obtain similar insurance coverage in the future, and any inability to recover under our insurance policies for damages sustained at our properties in the event of inclement weather and casualty events; whether the objective of a strategic alternative review process will be achieved; the terms, structure, benefits and costs of any strategic transaction; the timing of any strategic transaction and whether any strategic transaction will be consummated on the terms proposed or at all; the risk that the announcement or exploration of strategic alternatives could have an adverse effect on our ability to retain key personnel and maintain relationships with partners, suppliers, employees, shareholders and other business relationships; the risk of any unexpected costs or expenses resulting from the exploration of strategic alternatives; the risk of any litigation relating to the exploration of strategic alternatives or any strategic transaction; and other factors described under the heading “Risk Factors” in our most recent Annual Report on Form 10-K and in other filings we make with the Securities and Exchange Commission.

We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Contact: Sam Ullrich
(502) 638-3906
Sam.Ullrich@kyderby.com

This press release was published by a CLEAR® Verified individual.

ISS Recognizes There is No Case for Change

Anavex Urges Stockholders to Follow ISS’ Recommendation and Vote “FOR” ALL Six Director Nominees on the WHITE Proxy Card Today

NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or “the Company”), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system diseases with high unmet medical needs, today announced that leading independent proxy advisory firm Institutional Shareholder Services (“ISS”) has recommended that Anavex stockholders vote on the WHITE proxy card “FOR” all six of the Company’s highly qualified director nominees standing for election at the 2026 Annual Meeting of Stockholders – Dr. Jiong Ma, Dr. Peter Donhauser, Dr. Axel Paeger, Mr. Gautam Patel, Dr. Adrian Senderowicz and Dr. Claus van der Velden.

In its report issued on September 11, 2026, ISS noted the substantive plan and strategy underway at Anavex and concluded that “[t]he dissident has not made a compelling case for change.”1

In recommending “FOR” all six of the Anavex nominees on the WHITE proxy card, ISS also stated2:

  • “[The EMA opinion] appears to have been a turning point, after which the board assumed a more active role that resulted in removal of the CEO.”
  • “Since then, the board has also refreshed. Half of the board, when new nominees are included, is now composed of new members. It appears that the new board members bring experience in drug development, early-stage company development, and an understanding of the FDA approval process.”
  • “The board also appointed an interim CEO and is moving towards hiring a permanent CEO, CFO, and CMO.”

  • “Starting with the formation of the special committee and subsequent termination of the former CEO, the board appears to have acted decisively to remedy a situation that it admits was of its own making.”

The Executive Committee of Anavex’s Board issued the following statement:

ISS’ recommendation reaffirms that we have the right slate of Board nominees to continue driving long-term stockholder value and overseeing our new, focused strategy.

Our six nominees bring the biotechnology, clinical research, pharmaceutical development, regulatory and public company experience Anavex needs at this stage, and, if elected, half the Board will have been refreshed since the beginning of 2026, with every director as independent.

ISS agrees that “despite seeking a majority position, [PVG] has not presented a detailed go-forward plan.”3 We believe PVG’s slate, concentrated in investment management and equity research, would leave Anavex flailing and without focus, overseen by a Board deficient in the expertise that matters most.

We are grateful that ISS, after an independent review of both sides, is recommending “FOR” all six of our director nominees. We believe PVG’s attempt to seize control of the Board would disrupt Anavex’s progress at exactly the wrong moment for patients and stockholders alike.

Anavex strongly encourages all stockholders to follow ISS’ guidance and vote “FOR” ALL six of Anavex’s director nominees standing for election on their WHITE proxy card. For additional information on Anavex’s nominees and how to vote, visit www.VoteAnavex.com.

The Annual Meeting will be held on September 24, 2026, and stockholders of record as of the close of business on July 31, 2026 are entitled to vote.

Anavex stockholders with questions about or requiring assistance with voting shares, please call:

Innisfree M&A Incorporated
500 Fifth Avenue, 21st Floor
New York, NY 10110
Stockholders may call toll-free at (877) 750-0831
Brokers, banks and other nominees may call collect at (212) 750-5833

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsychiatric disorders. Further information is available at www.anavex.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements regarding the Company’s plans, strategies and expectations regarding the 2026 Annual Meeting, director nominations, the proxy solicitation, the Company’s go-forward strategy, clinical development programs, business prospects, and potential actions of the Board and the Executive Committee, are forward-looking statements. These statements can be identified by the use of forward-looking terminology, including the words “believes,” “anticipates,” “plans,” “estimates,” “expects,” “intends,” “may,” “will,” “would,” “could” and similar expressions, or the negative thereof. Many factors may cause actual results to differ materially from those projected in any of such forward-looking statements, including the risks and uncertainties set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2025, filed with the Securities and Exchange Commission (“SEC”) on November 25, 2025, the Company’s Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2025, filed with the SEC on February 9, 2026, the Company’s Form 10-K/A for the fiscal year ended September 30, 2025, filed with the SEC on August 28, 2026, the Company’s Form 10-Q/A for the quarterly period ended December 31, 2025, filed with the SEC on August 28, 2026, the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, filed with the SEC on August 28, 2026, the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, filed with the SEC on August 28, 2026, and subsequent filings and furnishings with the SEC, which should be considered together with any forward-looking statement. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Anavex Life Sciences Corp. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof except as required by law.

Important Additional Information and Where to Find It
The Company has filed a definitive proxy statement on Schedule 14A, an accompanying WHITE proxy card, and other relevant documents with the SEC in connection with the solicitation of proxies from the Company’s stockholders for the 2026 Annual Meeting. THE COMPANY’S STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ THE COMPANY’S DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), THE ACCOMPANYING WHITE PROXY CARD AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Stockholders are able to obtain the definitive proxy statement, any amendments or supplements to the proxy statement and other documents that the Company files with the SEC at no charge at the SEC’s website at www.sec.gov. Copies are also available at no charge at the Company’s website at www.anavex.com.

Certain Information Regarding Participants
The Company, its directors and certain of its executive officers may be deemed to be “participants” (as defined in Schedule 14A under the Securities Exchange Act of 1934, as amended) in the solicitation of proxies from the Company’s stockholders in connection with the matters to be considered at the 2026 Annual Meeting. Information regarding the names of the Company’s directors and executive officers and certain other individuals and their direct or indirect interests in the Company, by security holdings or otherwise, is set forth in the sections entitled “Compensation of Directors,” “Executive Compensation,” and “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” of the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2025 (available here), and any subsequent filings on Forms 3, 4 and 5 filed with the SEC. Additional information regarding the identity of potential participants, and their direct or indirect interests, by security holdings or otherwise, is set forth in the Company’s definitive proxy statement for the 2026 Annual Meeting which has been filed with the SEC. These documents are available free of charge at the SEC’s website at www.sec.gov.

Investor Relations:
SCR Partners, LLC
Alex Arzeno
Tel: 203-550-3972
Email: alex@scr-ir.com

Tripp Sullivan
Tel: 615-942-7077
Email: tsullivan@scr-ir.com

For Media:
Collected Strategies
Nick Lamplough / Dylan O’Keefe
AVXL-CS@collectedstrategies.com

_________________________________
1 Permission to use quotations neither sought nor obtained.
2 Permission to use quotations neither sought nor obtained.
3 Permission to use quotations neither sought nor obtained.

Under the terms of the Amendment, all disputed issues are resolved

SAN DIEGO and NERVIANO, Italy, Sept. 14, 2026 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (NASDAQ: CRDF) (“Cardiff”) and Nerviano Medical Sciences S.r.l. (“NMS”) today announced that they have reached a settlement and amended their 2017 Exclusive License Agreement, resolving all outstanding disputes between the two companies related to the global rights for onvansertib, Cardiff’s lead PLK1 inhibitor drug candidate, and establishing an expanded collaborative framework to support onvansertib’s continued clinical development.

Cardiff and NMS have agreed to a full and mutual release of all claims asserted in the litigation pending in the U.S. District Court for the Southern District of California. Cardiff and NMS plan to jointly request dismissal of all claims with prejudice.

“This Amendment strengthens our long-term rights to onvansertib as a promising treatment for cancer, beginning with first-line RAS-mutated metastatic colorectal cancer,” said Mani Mohindru, PhD, President and Chief Executive Officer of Cardiff Oncology. “We are pleased to be entering into this agreement with NMS, which reflects our shared commitment to bringing onvansertib to patients with high unmet need.”

“We look forward to working with Cardiff to advance onvansertib into a global Phase 3 study in first-line RAS-mutated metastatic colorectal cancer and to bring this therapy to patients,” said Hugues Dolgos, PharmD, Chief Executive Officer of NMS Group S.r.l.

The Parties clarified and expanded on the royalty structure in the License Agreement. The agreement also includes development objectives related to Cardiff’s upcoming Phase 3 program, as well as rights for NMS to appoint a Board observer and join Cardiff’s Scientific Advisory Board.

About Onvansertib
Onvansertib is a highly specific, oral PLK1 inhibitor advancing toward a registrational trial in first-line RAS-mutated mCRC. In a randomized Phase 2 trial, onvansertib in combination with FOLFIRI/bevacizumab (first-line standard-of-care) demonstrated dose-dependent improvements in overall response rate and progression-free survival compared to standard-of-care alone, building on findings from a prior Phase 2 trial in second-line RAS-mutated mCRC. Based on these results, the Company has selected the 30 mg dose of onvansertib in combination with FOLFIRI/bevacizumab for advancement into a registrational trial in first-line patients with RAS-mutated mCRC.

About Cardiff Oncology, Inc.
Cardiff Oncology is a clinical-stage biotechnology company advancing innovative cancer treatments focused on PLK1 inhibition, a validated oncology target with practice-changing potential. Cardiff’s lead asset, onvansertib, is a highly specific, oral PLK1 inhibitor currently being evaluated in a Phase 2 trial for first-line treatment of RAS-mutated mCRC, addressing a large, underserved patient population with high unmet need. Onvansertib is also under investigation in other PLK1-driven cancers through ongoing investigator-initiated trials and has shown robust single-agent clinical activity in hard-to-treat tumors. By targeting tumor vulnerabilities, we aim to overcome treatment resistance and deliver improved clinical outcomes for patients.

About NMS
NMS is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative oncology therapies. Building on a long-standing heritage in cancer biology and drug discovery, NMS combines a focused clinical-stage small-molecule portfolio with a differentiated ADC platform and an active discovery engine generating first-in-class oncology programs. NMS has operations in Italy, the United States, China and Hong Kong.

Forward-Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified using words such as “anticipate,” “believe,” “forecast,” “estimated” and “intend” or other similar terms or expressions that concern Cardiff Oncology’s expectations, strategy, plans or intentions. These forward-looking statements are based on Cardiff Oncology’s current expectations and actual results could differ materially. There are several factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, clinical trials involve a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future trial results; our clinical trials may be suspended or discontinued due to unexpected side effects or other safety risks that could preclude approval of our product candidate; results of preclinical studies or clinical trials for our product candidate could be unfavorable or delayed; our need for additional financing; risks related to business interruptions, including the outbreak of COVID-19 coronavirus and cyber-attacks on our information technology infrastructure, which could seriously harm our financial condition and increase our costs and expenses; uncertainties of government or third-party payer reimbursement; dependence on key personnel; limited experience in marketing and sales; substantial competition; uncertainties of patent protection and litigation; dependence upon third parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. There are no guarantees that our product candidate will be utilized or prove to be commercially successful. Additionally, there are no guarantees that future clinical trials will be completed or successful or that our product candidate will receive regulatory approval for any indication or prove to be commercially successful. Investors should read the risk factors set forth in Cardiff Oncology’s Form 10-K for the year ended December 31, 2025, and other periodic reports filed with the Securities and Exchange Commission. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Forward-looking statements included herein are made as of the date hereof, and Cardiff Oncology does not undertake any obligation to update publicly such statements to reflect subsequent events or circumstances.

For more information regarding Cardiff, please visit https://www.cardiffoncology.com.

Cardiff Investor Contact: 
Candice Masse 
Astr Partners 
candice.masse@astrpartners.com 

Cardiff Media Contact:
Amy Bonanno
Lyra Strategic Advisory
abonanno@lyraadvisory.com

For more information regarding NMS, please visit https://www.nervianoms.com/

NMS Media Contact: 
mediarelations@nervianoms.com

This transaction is in addition to the previously announced pending sale of Altruis Benefit Consulting

LAKEWOOD, NJ, Sept. 14, 2026 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: EZRA) (“Reliance,” “EZRA” or the “Company”), an InsurTech company leveraging artificial intelligence, cloud computing and advanced technologies to transform the insurance agency/brokerage industry, today announced that it has completed the sale of its Southwestern Montana Insurance Center subsidiary, a Montana-based full-service insurance agency, for $2.625 million in cash at closing, plus an uncapped earnout, if any, based on the agency’s EBITDA performance for the twelve months ending August 31, 2027. No shares were issued in connection with the transaction. The Southwestern Montana Insurance Center sale is in addition to the previously announced expected sale of the Michigan-based Altruis Benefit Consulting agency.

The completed transaction represents the continued execution of the portfolio monetization strategy of non-core agencies that Reliance launched in 2025. The Company is selectively monetizing mature insurance agency assets to strengthen its balance sheet and redeploy capital into its proprietary AI platform, RELI Exchange, other high-growth InsurTech initiatives, and accelerate the repayment of the company’s term debt.

Key Terms and Expected Impact

  • Cash at closing plus uncapped earnout; zero dilution. The Company received $2.625 million in cash at closing, based on a multiple of 8.75 times pro forma EBITDA of $300,000. In addition, the transaction provides for an uncapped earnout, if any, equal to 8.75 times the amount by which the agency’s EBITDA exceeds $300,000 for the twelve months ending August 31, 2027, payable, if earned, following the first anniversary of the closing. No shares were issued in connection with the transaction.
  • Transaction completed. The sale of Southwestern Montana Insurance Center closed on September 11, 2026, effective as of September 1, 2026, marking the successful completion of another transaction under the Company’s portfolio monetization strategy.
  • Continued execution of the strategy. The completed transaction represents further execution of a non-core agency divestiture under the Company’s portfolio monetization strategy and demonstrates the Company’s continued discipline in unlocking the value of Reliance’s non-core assets while increasing investment in higher-growth technology initiatives.
  • Enhanced financial flexibility. The completed transaction provides the Company with additional capital and financial flexibility to support operations, growth and strategic investment, including continued investment in its proprietary AI platform, RELI Exchange and other technology initiatives.

Strategic Rationale

In 2025, Reliance launched a portfolio monetization strategy to unlock the value of non-core insurance agency assets while accelerating its evolution into a technology-driven InsurTech company. By selectively monetizing established insurance operations, the Company expects to strengthen its balance sheet, improve financial flexibility and redeploy capital into its proprietary AI platform, RELI Exchange and other strategic growth initiatives that management believes offer greater long-term growth opportunities.

The completed Southwestern Montana transaction represents another milestone in executing the strategy. The transaction is expected to strengthen the Company’s financial position and increase the capital available to accelerate development of the Company’s proprietary AI platform, expand the RELI Exchange network and pursue additional strategic growth opportunities.

“The completed sale of Southwestern Montana Insurance Center reflects the continued execution of our portfolio monetization strategy, a disciplined capital allocation approach designed to unlock the value of our mature insurance agency portfolio and redeploy that capital into higher-growth opportunities,” said Ezra Beyman, Chairman and Chief Executive Officer of Reliance Global Group. “This transaction was driven by strategy and reflects our commitment to building a stronger, more focused technology-driven company while maximizing long-term shareholder value.”

“This closing builds on the momentum of our recent tech developments and represents another step in repositioning Reliance for its next phase of growth,” Mr. Beyman continued. “We believe this transaction provides us with greater financial flexibility and increased capacity to invest in our AI platform, RELI Exchange and other strategic growth initiatives. We believe this disciplined approach positions Reliance to create meaningful long-term value for our shareholders.”

About Reliance Global Group, Inc.

Reliance Global Group, Inc. (Nasdaq: EZRA) is an InsurTech company leveraging artificial intelligence, cloud computing and advanced technologies to transform the insurance agency/brokerage industry. Through its growing portfolio of proprietary AI solutions and insurance operations, the Company is focused on enhancing operational efficiency, improving customer experiences and creating long-term shareholder value. Further information about the Company can be found at https://www.relianceglobalgroup.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements other than statements of historical fact and may be identified by the use of words or expressions such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “target,” “project,” “potential,” or similar expressions, or by discussions of strategy, plans or intentions. Forward-looking statements in this press release include, without limitation, statements regarding: the amount, timing and payment of the earnout consideration, if any; the anticipated benefits of the completed sale of Southwestern Montana Insurance Center; the previously announced proposed sale of Altruis Benefit Consulting, including the negotiation and execution of definitive agreements and the timing of any closing; the Company’s intended use of proceeds and the anticipated effects of the transaction on the Company’s cash position, capital structure and financial flexibility; the Company’s portfolio monetization strategy, including the monetization of mature insurance distribution assets and the redeployment of capital; and the continued development, deployment and potential commercialization of the Company’s proprietary artificial intelligence platform and its RELI Exchange InsurTech platform.

These statements are based on management’s current expectations and assumptions and are subject to risks, uncertainties and other factors, many of which are beyond the Company’s control. Should one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may differ materially from those expressed or implied by these forward-looking statements.

Such risks and uncertainties include, without limitation: the risk that the earnout consideration is not earned or paid, in whole or in part, including because the EBITDA of the divested agency, which will be operated by the buyer following the closing, does not exceed the applicable threshold; the subordination of the Company’s right to receive the earnout consideration; the loss of the revenue and operating cash flow historically contributed by Southwestern Montana Insurance Center and the resulting impact on the Company’s consolidated results of operations; with respect to the proposed Altruis transaction, the risk that definitive agreements are not negotiated or executed, that closing conditions are not satisfied or waived, or that the transaction is delayed or terminated; the risk that the Company is unable to redeploy capital into initiatives that generate the anticipated returns; the Company’s ability to maintain compliance with the continued listing standards of The Nasdaq Capital Market; the Company’s ability to access additional capital on acceptable terms, or at all; the development, deployment, market acceptance and potential commercialization of the Company’s proprietary artificial intelligence technologies; competition, regulatory developments and other risks affecting the insurance brokerage and InsurTech industries; and general business, economic, market and geopolitical conditions. Additional information regarding these and other factors that may cause actual results to differ materially is included under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as amended, and in the Company’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission, copies of which are available free of charge at www.sec.gov.

Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements in this press release speak only as of the date of this press release. Except as required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Investor Relations Contact:
Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: EZRA@crescendo-ir.com

BOCA RATON, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) — NewtekOne, Inc. (“the Company”) (NASDAQ: NEWT) announced that its Board of Directors declared a quarterly cash dividend of $0.19 per share on the Company’s outstanding common stock. The dividend is payable on October 1, 2026, to shareholders of record as of September 24, 2026.

The Company’s Board of Directors also declared a dividend on the Company’s outstanding 8.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B (the “Preferred Shares”) (NASDAQ: NEWTP) in the amount of $21.25 per Preferred Share, or $0.53125 per depositary share, which is equivalent to 1/40th of the dividend on the Preferred Shares, payable on October 1, 2026, to holders of record as of September 24, 2026.

About NewtekOne, Inc.

NewtekOne®, Your Business Solutions Company®, is a financial holding company, which along with its bank and non-bank consolidated subsidiaries (collectively, “NewtekOne”), provides a wide range of business and financial solutions under the Newtek® brand to independent business owners. Since 1999, NewtekOne has provided state-of-the-art, cost-efficient products and services and efficient business strategies to independent business owners across all 50 states to help them grow their sales, control their expenses, and reduce their risk.

NewtekOne’s and its subsidiaries’ business and financial solutions include: banking (Newtek Bank, N.A.), Business Lending, SBA Lending Solutions, Electronic Payment Processing, eCommerce, Accounts Receivable Financing & Inventory Financing and Insurance Solutions, Web Services, and Payroll and Benefits Solutions. In addition, NewtekOne offers its clients the Technology Solutions (Cloud Computing, Data Backup, Storage and Retrieval, IT Consulting and Web Services) provided by Intelligent Protection Management Corp. (IPM.com).

Newtek®, NewtekOne®, Newtek Bank®, National Association, Your Business Solutions Company®, One Solution for All Your Business Needs® and Newtek Advantage are registered trademarks of NewtekOne, Inc.

Note Regarding Forward-Looking Statements
Certain statements in this press release are “forward-looking statements” within the meaning of the rules and regulations of the Private Securities Litigation and Reform Act of 1995 are based on the current beliefs and expectations of NewtekOne’s management and are subject to significant risks and uncertainties. Actual results may differ materially from those set forth in the forward-looking statements. See “Note Regarding Forward-Looking Statements” and the sections entitled “Risk Factors” in our filings with the Securities and Exchange Commission which are available on NewtekOne’s website (https://investor.newtekbusinessservices.com/sec-filings) and on the Securities and Exchange Commission’s website (www.sec.gov). Any forward-looking statements made by or on behalf of NewtekOne speak only as to the date they are made, and NewtekOne does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.

SOURCE: NewtekOne, Inc.

Investor Relations & Public Relations
Contact: Bryce Rowe
Telephone: (212) 273-8292 / browe@newtekone.com

Quarter-to-date, SOL has outperformed the Nasdaq-100 by 39%, and DFDV has outperformed SOL by 2x over that same period

CHAD ATM issuance is expected to occur at or above $10.00 per share, CHAD’s par value

Latest purchase expands treasury to 2,388,923 SOL and SOL equivalents

BOCA RATON, FL, Sept. 14, 2026 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first U.S. public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced that its total treasury holdings have grown by 55,491 SOL to approximately 2,388,923 SOL and SOL equivalents, an increase of approximately 2% since August 27, 2026, reflecting continued SOL purchases and organic treasury growth as the Company’s accumulation flywheel gains momentum.

The Company also announced that it has established an at-the-market (“ATM”) offering program for up to $300 million of its Variable Rate Series C Perpetual Preferred Stock (Nasdaq: CHAD) (“CHAD”). The shares will be offered pursuant to a sales agreement between the Company and R.F. Lafferty & Co., Inc., as sole sales agent. The Company intends to issue shares under the ATM program at or above $10.00 per share, CHAD’s par value. Net proceeds are intended primarily to fund additional SOL purchases.

Together, continued treasury growth and the new ATM capacity advance DFDV’s capital flywheel to raise capital, accumulate SOL, generate organic yield, and compound SOL per share (“SPS”) growth. With CHAD adding a new funding engine, the Company is expanding its ability to turn capital markets access into a larger productive asset base.

The SOL Accumulation Flywheel Is Gaining Momentum
“We are growing our SOL treasury, generating more organic yield, and delivering strong performance, with DFDV returning twice as much as SOL quarter-to-date,” said Joseph Onorati, Chief Executive Officer of DeFi Development Corp. “With a $300 million ATM now in place, we have the structure to scale CHAD into a meaningful new engine of growth—and we intend to  issue at or above $10.00 par. The flywheel is spinning, and we now have more capacity to put it to work.”

$300 Million CHAD ATM Provides Additional Funding Capacity
The ATM program allows the Company to raise capital through CHAD sales over time, subject to market conditions, investor demand and the Company’s capital needs. Establishing the program does not represent an immediate capital raise, and the Company is not obligated to sell any shares. All issuance under the program is intended to occur at or above $10.00 per share. Learn more about CHAD at www.defidevcorp.com/chad.

For more information, visit defidevcorp.com. To stay up to date with the latest developments and insights, subscribe to our blog.

About DeFi Development Corp.
DeFi Development Corp. (Nasdaq: DFDV) has adopted a treasury policy under which the principal holding in its treasury reserve is allocated to SOL. Through this strategy, the Company provides investors with direct economic exposure to SOL, while also actively participating in the growth of the Solana ecosystem. In addition to holding and staking SOL, DeFi Development Corp. operates its own validator infrastructure, generating staking rewards and fees from delegated stake. The Company is also engaged across decentralized finance (DeFi) opportunities and continues to explore innovative ways to support and benefit from Solana’s expanding application layer. The Company is also an AI-powered online platform that connects the commercial real estate industry by providing value-add services and software subscriptions to multifamily and commercial property professionals, as the Company connects the increasingly complex ecosystem that stakeholders have to manage. The Company’s data and software offerings are generally offered on a subscription basis as software as a service.

Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include, but are not limited to, statements regarding the anticipated issuance price of shares under the ATM program, the intended use of proceeds, and the Company’s ability to expand its SOL treasury and increase revenue, and can be identified by words such as “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations, and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) fluctuations in the market price of SOL and any associated losses that the Company may incur as a result of a decrease in the market price of SOL; (ii) a failure for the demand for SOL, or activity on the SOL network, to continue to develop and grow as predicted in our DFDV Model or at all; (iii) volatility in our stock price, including due to future issuances of common stock and securities convertible into common stock; (iv) the effect of and uncertainties related to the ongoing volatility in interest rates; (v) our ability to achieve and maintain profitability in the future; (vi) the impact on our business of the regulatory environment and complexities of complying with such environment, including changes in securities laws or other laws or regulations; (vii) changes in the accounting treatment relating to the Company’s SOL holdings; (viii) our ability to respond to general economic conditions; (ix) our ability to manage our growth effectively and our expectations regarding the development and expansion of our business; (x) our ability to access sources of capital, including debt financing and other sources of capital to finance operations and growth; and (xi) other risks and uncertainties more fully described in the section captioned “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and other reports we file with the SEC.

As a result of these matters, changes in facts, assumptions not being realized, or other circumstances, the Company’s actual results may differ materially from the expected results discussed in the forward-looking statements contained in this press release. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

Investor Contact:
ir@defidevcorp.com

Media Contact:
press@defidevcorp.com

Watsco to Expand its Growing Presence in Plumbing Products Distribution by 82 Locations

MIAMI, Sept. 14, 2026 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today that it has entered into an agreement to acquire The Granite Group, a diversified distributor of plumbing and HVAC products with approximately $500 million in sales throughout seven Northeast States. Watsco’s ownership culture, scale, OEM relationships and industry-leading technologies will be at the full disposal of Granite’s leadership team to help them accelerate beyond their impressive track record of growth.

Founded in 1971 and headquartered in Concord, New Hampshire, The Granite Group is a third-generation, family-led distributor serving customers across seven states in New Hampshire, Vermont, Maine, Massachusetts, Connecticut, Rhode Island and New York.

The Granite Group serves approximately 11,000 customers from 82 locations and offers approximately 29,000 SKUs sourced from over 450 vendors. The Granite Group has achieved a 10% annual compounded growth rate in sales since 2010 through a combination of bolt-on acquisitions and more than 30 new store openings to win new customers and better serve existing customers.

Watsco’s partnership with The Granite Group adds scale, density, product diversification and deepens Watsco’s market position in the growing plumbing space – a large and fragmented market that represents compelling avenues for expansion.

The Granite Group will operate as an independent business and will continue to be led by its existing management team, under the leadership of Bill Condron, in keeping with Watsco’s disciplined strategy of investing in great leadership teams and successful cultures. The transaction is expected to close following completion of customary closing conditions and regulatory approvals.

Albert H. Nahmad, Watsco’s Chairman and CEO said: “The Granite Group is one of the most respected, entrepreneurial businesses in our industry. For more than 50 years, the Condron family and their team have built a company defined by an extraordinary people-first culture, an entrepreneurial spirit that mirrors our own and an unwavering commitment to their customers. We look forward to their inclusion in our ownership culture and to support their plan for growth with our scale, capital and technology to build on their track record of success. We are pleased to become part of their family.”

Bill Condron, CEO of The Granite Group, commented: “We have long admired Watsco – its people, its culture and the values that have guided the company. We share similar cultures and think about the business in similar ways. Watsco was the logical choice for The Granite Group in that we remain independent while gaining access to Watsco’s scale, capital, and the most advanced technology platforms in the industry. We could not be more excited to join the Watsco family and pursue our ambitious growth plans together.”

Watsco’s Buy and Build Growth Strategy

Watsco has acquired 73 businesses in the HVAC and plumbing markets since 1989, most of which were successful, multi-generation, family-owned businesses. Watsco’s buy and build strategy can be summarized as follows:

  • Identify and partner with great distribution businesses
  • Support their leadership team and honor the culture and legacies they created
  • Ask for aggressive growth plans and help leadership achieve their ambitions 
  • Motivate teams and build an ownership culture with long-term equity
  • Deploy the industry’s most comprehensive suite of customer-focused technologies
  • Solicit and collaborate on big ideas to foster a spirit of innovation and growth
  • Build a stronger Watsco because of our association with these companies

On June 1, 2026, Watsco closed on the acquisition of Jackson Supply Company, a market-leading HVAC distributor with annualized sales of approximately $230 million across 25 Sunbelt locations. Jackson Supply offers a balanced product offering of HVAC equipment, parts and supplies. As importantly, Jackson Supply added to Watsco’s entrepreneurial community of leaders.

Watsco is actively seeking additional opportunities to invest and grow through acquisitions to expand its relatively low market share of the estimated $74 billion North American distribution marketplace.

About Watsco 

Watsco is the largest distributor in the highly fragmented North American HVAC market. Since entering distribution in 1989, Watsco has achieved an 18% compounded annual total shareholder return through a combination of organic growth and the acquisition of more than 70 market-leading businesses.

Watsco maintains a solid balance sheet, enabling sustained investments in growth, including the Company’s industry-leading technologies. Today, more than 70,000 contractors and technicians engage digitally, empowering them to adopt and integrate Watsco’s tools into their daily operations. The Company is also introducing AI-driven initiatives to leverage its extensive data assets and enrich the customer experience. The Company believes its technology ecosystem represents a durable and widening competitive advantage in its highly fragmented industry.

This document includes certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may address, among other things, our expected financial and operational results and the related assumptions underlying our expected results. These forward-looking statements are distinguished by use of words such as “will,” “would,” “anticipate,” “expect,” “believe,” “designed,” “plan,” or “intend,” the negative of these terms, and similar references to future periods. These statements are based on management’s current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these expectations due to changes in economic, business, competitive market, new housing starts and completions, capital spending in commercial construction, consumer spending and debt levels, regulatory and other factors, including, without limitation, the effects of supplier concentration, competitive conditions within Watsco’s industry, the seasonal nature of sales of Watsco’s products, the ability of the Company to expand its business, insurance coverage risks and final GAAP adjustments. Detailed information about these factors and additional important factors can be found in the documents that Watsco files with the Securities and Exchange Commission, such as Form 10-K, Form 10-Q and Form 8-K. Forward-looking statements speak only as of the date the statements were made. Watsco assumes no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except as required by applicable law.

Barry S. Logan
Executive Vice President
(305) 714-4102
e-mail: blogan@watsco.com  

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.